Understanding Fmoc-D-Asn(Trt)-OH: A Foundation for Peptide Synthesis Excellence
The synthesis of peptides, which are increasingly vital in pharmaceutical research and therapeutic applications, demands precision and high-quality reagents. Among these, protected amino acids are indispensable, and Fmoc-D-Asn(Trt)-OH (CAS 180570-71-2) serves as a prime example of such a critical building block. This article highlights the importance of Fmoc-D-Asn(Trt)-OH in peptide synthesis and its significance as a pharmaceutical intermediate.
Fmoc-D-Asn(Trt)-OH is a derivative of D-asparagine, featuring two key protecting groups: the Fmoc (9-fluorenylmethoxycarbonyl) group on the alpha-amino nitrogen and the trityl (Trt) group on the side-chain amide. These protective groups are essential for successful solid-phase peptide synthesis (SPPS). The Fmoc group allows for selective deprotection under mild basic conditions, facilitating the controlled addition of subsequent amino acids. The trityl group offers stability to the side chain during the synthesis process and is typically cleaved during the final resin cleavage step, ensuring the integrity of the newly formed peptide.
A significant advantage of using Fmoc-D-Asn(Trt)-OH is the incorporation of the D-isomer of asparagine. Peptides that include D-amino acids are known to possess greater resistance to enzymatic degradation by proteases in the body. This characteristic is highly beneficial for peptide-based drugs, as it can extend their therapeutic half-life and improve their overall efficacy. Consequently, Fmoc-D-Asn(Trt)-OH is a valuable tool for researchers aiming to create more stable and potent peptide therapeutics.
As a widely recognized pharmaceutical intermediate, Fmoc-D-Asn(Trt)-OH is integral to numerous drug discovery and development programs. Researchers utilize it for synthesizing a variety of peptide structures, including peptide hormones, neuropeptides, and peptidomimetics. The consistent supply of high-purity Fmoc-D-Asn(Trt)-OH from reliable manufacturers and suppliers is crucial for the efficiency and success of these complex synthetic endeavors.
When procuring Fmoc-D-Asn(Trt)-OH, meticulous attention to product quality is paramount. Suppliers typically provide comprehensive specifications, with a minimum purity of ≥99% (HPLC) being a common standard. Manufacturers, including those in China, play a significant role in the global supply of this essential reagent, often offering competitive pricing. The price of Fmoc-D-Asn(Trt)-OH can fluctuate, but it is vital to prioritize product integrity and consistency to avoid potential complications in synthesis.
In conclusion, Fmoc-D-Asn(Trt)-OH (CAS 180570-71-2) is a foundational protected amino acid for high-quality peptide synthesis. Its strategic protective groups and the inherent stability conferred by the D-amino acid make it an indispensable resource for advancing peptide-based drug development and pharmaceutical research.
Fmoc-D-Asn(Trt)-OH is a derivative of D-asparagine, featuring two key protecting groups: the Fmoc (9-fluorenylmethoxycarbonyl) group on the alpha-amino nitrogen and the trityl (Trt) group on the side-chain amide. These protective groups are essential for successful solid-phase peptide synthesis (SPPS). The Fmoc group allows for selective deprotection under mild basic conditions, facilitating the controlled addition of subsequent amino acids. The trityl group offers stability to the side chain during the synthesis process and is typically cleaved during the final resin cleavage step, ensuring the integrity of the newly formed peptide.
A significant advantage of using Fmoc-D-Asn(Trt)-OH is the incorporation of the D-isomer of asparagine. Peptides that include D-amino acids are known to possess greater resistance to enzymatic degradation by proteases in the body. This characteristic is highly beneficial for peptide-based drugs, as it can extend their therapeutic half-life and improve their overall efficacy. Consequently, Fmoc-D-Asn(Trt)-OH is a valuable tool for researchers aiming to create more stable and potent peptide therapeutics.
As a widely recognized pharmaceutical intermediate, Fmoc-D-Asn(Trt)-OH is integral to numerous drug discovery and development programs. Researchers utilize it for synthesizing a variety of peptide structures, including peptide hormones, neuropeptides, and peptidomimetics. The consistent supply of high-purity Fmoc-D-Asn(Trt)-OH from reliable manufacturers and suppliers is crucial for the efficiency and success of these complex synthetic endeavors.
When procuring Fmoc-D-Asn(Trt)-OH, meticulous attention to product quality is paramount. Suppliers typically provide comprehensive specifications, with a minimum purity of ≥99% (HPLC) being a common standard. Manufacturers, including those in China, play a significant role in the global supply of this essential reagent, often offering competitive pricing. The price of Fmoc-D-Asn(Trt)-OH can fluctuate, but it is vital to prioritize product integrity and consistency to avoid potential complications in synthesis.
In conclusion, Fmoc-D-Asn(Trt)-OH (CAS 180570-71-2) is a foundational protected amino acid for high-quality peptide synthesis. Its strategic protective groups and the inherent stability conferred by the D-amino acid make it an indispensable resource for advancing peptide-based drug development and pharmaceutical research.
Perspectives & Insights
Molecule Vision 7
“A significant advantage of using Fmoc-D-Asn(Trt)-OH is the incorporation of the D-isomer of asparagine.”
Alpha Origin 24
“Peptides that include D-amino acids are known to possess greater resistance to enzymatic degradation by proteases in the body.”
Future Analyst X
“This characteristic is highly beneficial for peptide-based drugs, as it can extend their therapeutic half-life and improve their overall efficacy.”